#Denmark #Water Technology #Kongens Lyngby #capital raising #Aquaporin A/S

Aquaporin A/S Announces Extraordinary General Meeting

Aquaporin A/S, a pioneering company in water technology, is taking steps to engage its shareholders with an extraordinary general meeting scheduled for December 1, 2025. The meeting will take place at 16:30 CET at the company's office in Kongens Lyngby, Denmark. This is a significant event, as it aims to discuss crucial proposals that may influence the company’s financial trajectory and future operations.

As stated by the Board of Directors, the meeting's agenda revolves around a strategic review that Aquaporin has initiated. The primary aim is to explore diverse opportunities to raise essential capital through various avenues, including equity financing or strategic partnerships. The company has estimated that an influx of capital between DKK 125 million and DKK 175 million is necessary. This funding will not only support the ongoing capital requirements but also bolster the firm's growth ambitions until profitability is achieved in the near to mid-term.

Proposed Changes to Articles of Association

During the extraordinary general meeting, several proposals will be presented for discussion and vote. These proposals include amendments to the Articles of Association, which grant the Board of Directors specific authorizations regarding share capital increases. The amendments are designed to provide the necessary flexibility to accomplish potential transactions and capital-raising efforts.

The key proposals outlined include:
1. Authorization for Share Capital Increase with Pre-emptive Rights: A new proposal will allow the Board to increase share capital with pre-emptive rights for existing shareholders, potentially at a below-market price.
2. Authorization for Share Capital Increase without Pre-emptive Rights: The Board will also seek permission to raise capital without offering pre-emptive rights to current shareholders, but at or above market prices.
3. Interest of Non-shareholders: Another amendment aims to authorize capital increases without pre-emptive rights for existing shareholders at prices below market, primarily benefitting entities other than shareholders and employees of Aquaporin.
4. Combined Authorizations: Lastly, there will be a proposal for setting a combined maximum for the authorizations presented under agenda items one and three, provided each authorization is accepted.

Shareholders are encouraged to actively participate in this pivotal meeting as it marks a critical juncture for Aquaporin. To facilitate attendance, shareholders must notify the company of their intention to participate by November 27, 2025, at 23:59 CET.

About Aquaporin A/S

Aquaporin A/S, headquartered in Denmark, operates in various countries including Singapore, Turkey, the United States, and China. The company's mission centers on revolutionizing water filtration through innovative biotechnology, addressing global water challenges. Their product leverages the unique Aquaporin Inside® technology, inspired by natural processes, which has been developed based on Nobel Prize-winning research.

With its range of applications, Aquaporin focuses on purifying and recycling water in both industrial settings and households. Their collaborations span across industries, ensuring that water treatment is handled responsibly and effectively. With a vision rooted in sustainable practices, Aquaporin is at the forefront of solving pressing water quality and accessibility issues worldwide.

Conclusion

As Aquaporin prepares for its extraordinary general meeting, shareholders are presented with an opportunity to influence the strategic direction of the company. The proposed changes aim not only to strengthen the financial position but also to ensure Aquaporin continues to innovate and lead in water technology. This meeting serves as a vital platform for engagement and reflection on the company's future path, furthering the commitment to resolving important water challenges globally.